{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T13:32:05Z","timestamp":1781530325626,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.prp.2023.154951","type":"journal-article","created":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T20:24:33Z","timestamp":1700511873000},"page":"154951","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["ALK-rearranged renal cell carcinoma (ALK-RCC): Evaluation of histomorphological and immunohistochemical features by analysis of 276 renal cell carcinoma cases in Turkey"],"prefix":"10.1016","volume":"253","author":[{"given":"Kutsal","family":"Do\u011fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evrim","family":"Onder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2023.154951_bib1","unstructured":"H. Moch, P.A. Humprey, T.M. Ulbright, V.E. Reuter, WHO Classification of Tumours of the Urinary System and Male Genital Organs, 4th ed., 2016."},{"key":"10.1016\/j.prp.2023.154951_bib2","article-title":"Classification of Tumours Editorial Board","volume":"Volume 8","author":"WHO","year":"2022"},{"key":"10.1016\/j.prp.2023.154951_bib3","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/gcc.20839","article-title":"ALK rearrangement in sickle cell trait-associated renal medullary carcinoma","volume":"50","author":"Mari\u00f1o-Enr\u00edquez","year":"2011","journal-title":"Genes. Chromosomes Cancer"},{"key":"10.1016\/j.prp.2023.154951_bib4","first-page":"430","article-title":"Renal cell carcinoma with novel VCL-ALK fusion: new representative of ALK-associated tumor spectrum","volume":"24","author":"Debelenko","year":"2011","journal-title":"Mod. Pathol. Off. J. U.S. Can. Acad. Pathol. Inc."},{"key":"10.1016\/j.prp.2023.154951_bib5","article-title":"Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia","author":"Trpkov","year":"2021","journal-title":"Mod. Pathol. Off. J. U. S. Can. Acad. Pathol. Inc."},{"key":"10.1016\/j.prp.2023.154951_bib6","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1097\/PAS.0000000000001476","article-title":"Report from the international society of urological pathology (ISUP) consultation conference on molecular pathology of urogenital cancers: III: Molecular pathology of kidney cancer","volume":"44","author":"Williamson","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.154951_bib7","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1038\/s41379-020-0578-0","article-title":"ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217","volume":"33","author":"Kuroda","year":"2020","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2023.154951_bib8","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.eururo.2018.03.032","article-title":"Responses to alectinib in alk-rearranged papillary renal cell carcinoma","volume":"74","author":"Pal","year":"2018","journal-title":"Eur. Urol."},{"key":"10.1016\/j.prp.2023.154951_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2019.152669","article-title":"ALK-rearranged renal cell carcinomas in Polish population","volume":"215","author":"Gorczynski","year":"2019","journal-title":"Pathol. - Res. Pract."},{"key":"10.1016\/j.prp.2023.154951_bib10","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1097\/00000478-200306000-00005","article-title":"Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay","volume":"27","author":"Argani","year":"2003","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.154951_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/his.13185","article-title":"Genetic analysis and clinicopathological features of ALK-rearranged renal cell carcinoma in a large series of resected Chinese renal cell carcinoma patients and literature review","volume":"71","author":"Yu","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2023.154951_bib12","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/gcc.22382","article-title":"Expanding the spectrum of ALK-rearranged renal cell carcinomas in children: Identification of a novel HOOK1-ALK fusion transcript","volume":"55","author":"Cajaiba","year":"2016","journal-title":"Genes. Chromosomes Cancer"},{"key":"10.1016\/j.prp.2023.154951_bib13","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/gcc.22346","article-title":"ALK-rearranged renal cell carcinomas in children","volume":"55","author":"Cajaiba","year":"2016","journal-title":"Genes. Chromosomes Cancer"},{"key":"10.1016\/j.prp.2023.154951_bib14","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.prp.2016.07.004","article-title":"TFE3-positive renal cell carcinomas are not always Xp11 translocation carcinomas: Report of a case with a TPM3-ALK translocation","volume":"212","author":"Thorner","year":"2016","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154951_bib15","doi-asserted-by":"crossref","DOI":"10.1186\/s13000-019-0879-0","article-title":"ALK-TPM3 rearrangement in adult renal cell carcinoma: a case report and literature review","volume":"14","author":"Yang","year":"2019","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.prp.2023.154951_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2019.152651","article-title":"Targeted next-generation sequencing revealed distinct clinicopathologic and molecular features of VCL-ALK RCC: A unique case from an older patient without clinical evidence of sickle cell trait","volume":"215","author":"Wang","year":"2019","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.prp.2023.154951_bib17","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00428-020-02752-5","article-title":"ALK-rearranged renal cell carcinoma with a novel PLEKHA7-ALK translocation and metanephric adenoma-like morphology","volume":"476","author":"Hang","year":"2020","journal-title":"Virchows Arch."},{"key":"10.1016\/j.prp.2023.154951_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.18.00185","article-title":"ALK fusions in renal cell carcinoma: response to entrectinib","author":"Tao","year":"2018","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.prp.2023.154951_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cancergen.2017.11.010","article-title":"ALK-TPM3 rearrangement in adult renal cell carcinoma: Report of a new case showing loss of chromosome 3 and literature review","volume":"221","author":"Bodokh","year":"2018","journal-title":"Cancer Genet"},{"key":"10.1016\/j.prp.2023.154951_bib20","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1177\/10668969211003660","article-title":"ALK-rearranged renal cell carcinoma (RCC): A report of 2 cases and review of the literature emphasizing the distinction between VCL-ALK and Non-VCL-ALK RCC","volume":"29","author":"Wangsiricharoen","year":"2021","journal-title":"Int. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.154951_bib21","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/PAS.0000000000000179","article-title":"VCL-ALK renal cell carcinoma in children with sickle-cell trait: the eighth sickle-cell nephropathy?","volume":"38","author":"Smith","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.154951_bib22","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1002\/cncr.27391","article-title":"Identification of anaplastic lymphoma kinase fusions in renal cancer: large-scale immunohistochemical screening by the intercalated antibody-enhanced polymer method","volume":"118","author":"Sugawara","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2023.154951_bib23","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/PAS.0000000000000610","article-title":"Two cases of renal cell carcinoma harboring a novel STRN-ALK fusion gene","volume":"40","author":"Kusano","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2023.154951_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12010168","article-title":"ESC, ALK, HOT and LOT: three letter acronyms of emerging renal entities knocking on the door of the WHO classification","volume":"12","author":"Siadat","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prp.2023.154951_bib25","first-page":"1516","article-title":"ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients","volume":"25","author":"Sukov","year":"2012","journal-title":"Mod. Pathol. . J. U. S. Can. Acad. Pathol. Inc."},{"key":"10.1016\/j.prp.2023.154951_bib26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.5114\/pjp.2018.76693","article-title":"A review of ALK-rearranged renal cell carcinomas with a focus on clinical and pathobiological aspects","volume":"69","author":"Kuroda","year":"2018","journal-title":"Pol. J. Pathol."},{"key":"10.1016\/j.prp.2023.154951_bib27","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.eururo.2015.10.049","article-title":"Everolimus versus sunitinib prospective evaluation in metastatic non-clear cell renal cell carcinoma (ESPN): a randomized multicenter phase 2 trial","volume":"69","author":"Tannir","year":"2016","journal-title":"Eur. Urol."},{"key":"10.1016\/j.prp.2023.154951_bib28","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.1200\/jco.2015.33.15_suppl.4507","article-title":"Final clinical results of a randomized phase II international trial of everolimus vs. sunitinib in patients with metastatic non-clear cell renal cell carcinoma (ASPEN)","volume":"33","author":"Armstrong","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2023.154951_bib29","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2007.13.3223","article-title":"Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma","volume":"26","author":"Choueiri","year":"2008","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.prp.2023.154951_bib30","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1093\/annonc\/mdr586","article-title":"Multicenter phase II study of sunitinib in patients with non-clear cell renal cell carcinoma","volume":"23","author":"Lee","year":"2012","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823006520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033823006520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T11:50:18Z","timestamp":1730893818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033823006520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":30,"alternative-id":["S0344033823006520"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2023.154951","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ALK-rearranged renal cell carcinoma (ALK-RCC): Evaluation of histomorphological and immunohistochemical features by analysis of 276 renal cell carcinoma cases in Turkey","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2023.154951","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154951"}}